Indian Pharmaceutical Congress 73rd Edition Advocates Strengthening Pharma Education and Digital Innovation
The ongoing Indian Pharmaceutical Congress (IPC) in Hyderabad has highlighted the critical need to bolster pharmaceutical education as a cornerstone for advancing manufacturing capabilities, pioneering R&D programs, and integrating digital technologies. At the forefront of discussions is the proposal to establish a Pharma University with a Centre of Excellence in Telangana, aimed at elevating global recognition in life sciences.
Telangana, renowned for its contributions to bulk drugs, vaccine development, and pharmaceutical formulations, emerges as the preferred location for this initiative. State officials underscored Telangana’s significant role, contributing 40% to India’s export earnings and housing a substantial pool of skilled pharmacy professionals.
Duddilla Sridhar Babu, Telangana’s Minister for Information Technology and Industries, affirmed the state’s commitment to realizing the Pharma University. “With over 200 pharmacy colleges and a robust workforce, Telangana is poised to establish a dedicated institution that will set benchmarks in pharmaceutical education,” stated Minister Babu during the IPC’s inaugural session at Hitex.
The event, graced by Telangana’s Deputy Chief Minister Mallu Bhatti Vikramarka and Minister for Roads, Buildings, and Cinematography Komatireddy Venkat Reddy, highlighted the state’s broader initiatives in skill development and digital technology integration. Minister Babu emphasized the necessity of adapting to the era of artificial intelligence and robotics, aligning with the IPC’s theme, ‘Role of India Pharma for Global Wellbeing.’
“Increasing workforce capabilities with advanced skills and digital expertise is paramount,” noted Babu. “Our focus is to leverage these advancements to gain a competitive edge internationally.”
Deputy Chief Minister Mallu Bhatti Vikramarka further outlined Telangana’s plans to establish Pharma Points of Production across districts, aiming to decentralize manufacturing hubs and stimulate local employment. Additionally, he announced plans for an Artificial Intelligence City to streamline digital technology adoption in manufacturing processes, ensuring efficiency and transparency.
The IPC, hosting 12,888 delegates and featuring 12 conference tracks, serves as a platform for industry leaders to discuss breakthroughs in drug development, biologicals, vaccines, and novel drug delivery devices. The congress underscores India’s pivotal role in producing affordable, high-quality medicines and vaccines for global healthcare.
As discussions at the IPC continue to shape the future of pharmaceutical education and innovation, stakeholders envision a robust framework that not only meets current challenges but also propels India’s pharmaceutical sector towards global leadership in healthcare solutions.